Viral and metabolic factors influencing alanine aminotransferase (ALT) activity in patients with chronic hepatitis C receiving peginterferon alfa-2a (40KD) (PEGASYS (R)) and ribavirin (COPEGUS (R)) in randomized phase III trials
HEPATOLOGY(2005)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要